SLSNSOLESENCE, INC.
Health Care
Operating Income (Loss) revised down 38.9% for Q2 2026
This is the 4th largest revision in SLSN's history.
Operating Income (Loss)·Q2 2026
Major restatement-$700K▼ 38.9%
was-$504K
Revised down in a 10-Q.
Verify against SEC filingsShow
As reported-$504K
Accepted 2026-05-120001999371-26-010555
Restated-$700K
Accepted 2026-08-190001999371-26-018231
OperatingIncome · reported 2 times · point-in-time, survivorship-free. Every figure traces to its filing above.
Track this the moment it happens
Get a signal the next time SLSN — or any company on your watchlist — restates a number. Every signal lands with the diff and its source filing.